Head-to-head · WeighScore
Concierge MD LA vs Virta Health
The verdict
Concierge MD LA takes it — 60.1/100 to 59.7/100, but only just.
Concierge MD LA grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Concierge MD LA offers semaglutide ($199/mo) and tirzepatide ($299/mo) alongside brand-name Ozempic, Mounjaro, Zepbound, and Wegovy ($1,999/mo each). Virta Health is close behind and may still be the better fit — see the factor split below.
We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.
Factor by factor
The same six graded dimensions, side by side. See the methodology.
The numbers
| Metric | Concierge MD LA | Virta Health |
|---|---|---|
| WeighScore | 60.1/100 | 59.7/100 |
| Grade | C | C |
| Scorecard rank | #328 | #336 |
| Semaglutide | $1,999/mo (brand Ozempic) | Not disclosed |
| Tirzepatide | $299/mo (plus a separate fee, compounded) | Not disclosed |
| Coverage | Coverage not published | Coverage not published |
| Brand-name access | Yes | Compounded only |
| Oral / sublingual | Injection only | Yes |
Graded #328 · C
Strengths
- Both compounded and brand-name GLP-1 options
- In-home medical services in major cities
- Competitive compounded pricing ($199/$299)
- Broader concierge medicine services available
Where it loses points
- No visible LegitScript or PCAB accreditation
- No physical address disclosed
- Limited to LA, NY, and 25+ cities — not nationwide
- Brand-name options at $1,999/mo — very high
- Semaglutide bills $199/mo but ships only every 90 days (tirzepatide every 60 days); 4-month minimum commitment required
Graded #336 · C
Strengths
- Offers a Responsible Prescribing track with optimized GLP-1 use
- Clinically monitored medication off-ramp toward nutrition therapy
- Nutrition-first model shown to rival GLP-1 weight loss (about 13% at 1 year)
- Provided at no cost to members through employers and health plans
- Strong evidence base for diabetes reversal and metabolic health
Where it loses points
- Primarily a nutrition program; GLP-1s are a secondary track
- Distributed via employers and health plans, no direct cash-pay
- Deliberately discourages GLP-1 use for most members
- GLP-1 access depends on the specific program the plan selects
Also worth a look
Neither is our top-graded pick — CoreAge Rx leads the scorecard
Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.